Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Gross Profit came in at $12.0 million in Q4 2025, up 65.56% YoY from $7.3 million in Q4 2024, and up 1.79% on a QoQ basis from $11.8 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Gross Profit (2023 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 3 years of Gross Profit data on file, last reported at $12.0 million in Q4 2025.
- Quarterly Gross Profit rose 65.56% year-over-year to $12.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $40.9 million (down 7.84% YoY) and the FY2025 annual result came in at $40.9 million, down 7.84% from the prior year.
- Gross Profit climbed to $12.0 million in Q4 2025, from $11.8 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $24.8 million in Q1 2024 to a low of $1.6 million in Q1 2023.
- A 3-year average of $8.8 million and a median of $7.8 million in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2024 — Gross Profit surged 1469.34% — and 2025, when it slumped 66.25%.
- Tracing FENC's Gross Profit over 3 years: stood at $9.0 million in 2023, then decreased by 19.82% to $7.3 million in 2024, then surged by 65.56% to $12.0 million in 2025.
- The last three Gross Profit figures came in at $12.0 million (Q4 2025), $11.8 million (Q3 2025), and $8.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.15 Mn |
| Jun 30, 2026 | 17.15 Mn |
| Dec 31, 2025 | 12.01 Mn |
| Dec 31, 2025 | 12.01 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Mar 31, 2025 | 8.38 Mn |
| Mar 31, 2025 | 8.38 Mn |
| Dec 31, 2024 | 7.26 Mn |
| Dec 31, 2024 | 7.26 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Sep 30, 2024 | 5.62 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Mar 31, 2024 | 24.83 Mn |
| Mar 31, 2024 | 24.83 Mn |
| Dec 31, 2023 | 9.05 Mn |
| Dec 31, 2023 | 9.05 Mn |